Clinical Trial Update: Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 18F-Florastamin PET/CT imaging for suspected recurrence of prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Florastamin (Fluorine-18 Florastamin)

Snippet

Sponsor: HTA Co., Ltd. | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING